Dr. Theodorou is interested in personalized medicine for cancer. She focuses on the development of novel targeted immunotherapies, using cutting-edge gene editing technologies. Taking advantage of the inherent characteristics of the tumor and the features of the patient’s immune system, she aims to contribute into the translation of personalized therapeutic approaches in clinical practice
